FGR and ovarian serous cystadenocarcinoma: We found three WASF2–FGR fusions (in lung squamous carcinoma, ovarian serous cystadenocarcinoma and skin cutaneous melanoma), harbouring the exact same breakpoints in all cases (Supplementary Figs 13 and 14).